In homogeneous catalysis, the catalyst is in the same phase as the reactant. The number of collisions between reactants and catalyst is at a maximum.In a patent, 497-25-6, name is Oxazolidin-2-one, introducing its new discovery. category: oxazolidine
Asymmetric beta-boration of alpha,beta-unsaturated N -acyloxazolidinones by [2.2]paracyclophane-based bifunctional catalyst
An efficient copper-catalyzed asymmetric conjugate boration has been achieved by exploiting a new planar and central chiral bicyclic triazolium ligand. This protocol was highly efficient and gave a variety of chiral secondary alkylboronates in 97-99% ee. A preliminary mechanistic study supports the bifunctional nature of the catalyst.
We¡¯ll also look at important developments in the pharmaceutical industry because understanding organic chemistry is important in understanding health, medicine, the role of 497-25-6, and how the biochemistry of the body works.category: oxazolidine
Reference£º
Oxazolidine – Wikipedia,
Oxazolidine | C3H1205NO – PubChem